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Background: Although most reports describing patients infected with methicillin-resistant Staphylococcus aureus
enterocolitis have been published in Japan, this concept remains a matter of debate and diagnostic criteria have
not yet been defined.
Case presentation: The general status of a 74-year-old Japanese man referred to our hospital (day 1) with severe
community-acquired pneumococcal pneumonia gradually improved with antibiotic therapy. Thereafter, up to 4
L/day of acute watery diarrhea that started on day 19 was refractory to metronidazole but responded immediately
to oral vancomycin. Gram staining stool samples was positive for abundant fecal leukocytes from which dominant
methicillin-resistant Staphylococcus aureus (104 CFU/mL) were isolated, suggesting methicillin-resistant Staphylococcus
aureus enterocolitis. High fever with methicillin-resistant Staphylococcus aureus bacteremia was evident at day 30,
and suppurative right hip arthritis developed around day 71. All methicillin-resistant Staphylococcus aureus strains
isolated from stools, blood and aspirated synovial fluid separated in the same manner on pulsed-field gel
electrophoresis, as well as two other strains isolated from sputum, belonged to the same clone as sequence
type (ST) 764 (complex clonal 5), and carried SCCmec type II.
Conclusion: The clinical, microbiological and molecular biological findings of this patient indicated methicillin-
resistant Staphylococcus aureus enterocolitis that led to septic methicillin-resistant Staphylococcus aureus arthritis.
Keywords: Methicillin-resistant Staphylococcus aureus, Fecal leukocytes, Multilocus sequence typingBackground
We describe a 74-year-old man who was diagnosed with
methicillin-resistant Staphylococcus aureus (MRSA) en-
terocolitis that subsequently caused septic arthritis. We
reviewed reports of MRSA enterocolitis published in
Japan over the past 10 years and characterized the clin-
ical features of MRSA enterocolitis. Here, we discuss the
clinical significance of staphylococcal enterotoxins (SEs)
and toxic shock syndrome toxin-1 (TSST-1).* Correspondence: sara@yd5.so-net.ne.jp
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stated.Case presentation
A 74-year-old Japanese man was transferred to our de-
partment from a local hospital under a diagnosis of
pneumonia. He had been in good health five days before
transfer to our hospital, but with pyrexia and dyspnea
upon effort. He had been treated with oral antihypergly-
cemic drugs to control type 2 diabetes mellitus five years
previously. He was a carpenter who did not consume al-
cohol, but had a smoking history of 44 pack-years. Al-
though he could walk unaided, he seemed very ill. His
consciousness level was E4V5M6 (Glasgow coma scale),
and his vital signs were: blood pressure, 90/50 mmHg;
temperature, 37.3°C; heart rate, 86 beats per min with
sinus rhythm; respiratory rate, 24 breaths per minute;
and oxygen saturation, 78% with an oxygen supply of
10 L/min delivered via a reservoir mask. He wasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Physical findings were normal except for coarse crackles
in the bilateral middle to lower lung fields. Upon admis-
sion to our hospital (day 1), a chest X-ray revealed infil-
tration throughout all lung fields except the left upper
lung. These results together with positive findings of
pneumococcal urinary antigens indicated a diagnosis of
pneumococcal pneumonia (CURB 65 score was 3, which
is defined as Confusion, Urea nitrogen, Respiratory rate,
Blood pressure, and 65 years of age and older; pneumo-
nia severity index was class IV). He was immediately
intubated and treated with intravenous meropenem
(1.5 g/day) plus ciprofloxacin (600 mg/day), which grad-
ually improved his respiratory status over a period of
two weeks. However, acute watery diarrhea amounting
to 4 L/day (determined by inserting a rectal tube)
together with pyrexia (38°C) was evident on day 19
(Figure 1). Although stool specimens were negative for
Clostridium difficile toxins A and B, pseudomembranous
colitis was considered and metronidazole (1 g/day) was
started via a nasogastric tube (Figure 1). However, the
watery diarrhea was refractory to metronidazole, and
Gram staining stool samples revealed abundant fecal
leukocytes (Figure 2), suggesting colonic membranous
damage. Although colonic fiberscopy on day 22 provided
limited information only as far as the sigmoid portion
because the health status of the patient was unstable, de-
finitive evidence of pseudomembranous formation otherFigure 1 Clinical course of the patient. Abbreviations: CLDM, clindamyci
meropenem; MRSA, methicillin-resistant Staphylococcus aureus; MZN, metrothan membranous edema or hyperemia was not found.
Furthermore, methicillin-resistant Staphylococcus aureus
(MRSA; 104 colony forming unit/mL) was predomin-
antly isolated from stool cultures on day 19 whereas
other enteric bacterial pathogens and parasites or ova
were negative, indicating MRSA enterocolitis. Vanco-
mycin (VCM; 1 g/day) delivered via a nasogastric tube
completely resolved the watery diarrhea within a few
days. However, at day 30, high fever recurred with mod-
erate watery diarrhea (~500 mL/day), and one of two
sets of blood cultures was positive for MRSA. Thereafter,
intravenous VCM (0.5 g/day) with dose adjustment for
renal dysfunction was initiated, and repeated blood cul-
tures were negative for MRSA. The total amount of
watery diarrhea excreted between days 19 and 34 was
22.43 L and the maximum volume per 24 h reached
3.50 L on day 25.
The general status of the patient gradually improved
except for persistent low-grade fever, and he was able to
walk unaided by day 64. Intermittent pain in the right
hip joint started on day 71 after he started rehabilitation
for walking (Figure 1). A physical examination revealed
the obturator or psoas sign, and he was positive for the
Gaenslen maneuver, suggesting inflammation at the
retroperitoneal or lumbar vertebrae and/or sacroiliac
joint. We explored the source of the fever and right hip
joint pain using magnetic resonance imaging (MRI)
(Figure 3A and B) and 67gallium scintigraphy of the hipn; CPFX, ciprofloxacin; DIV, drip infusion; LZD, linezolide; MEPM,
nidazole; TEIC, teicoplanin; VCM, vancomycin.
Figure 2 Gram staining findings of stool cultures. Fecal
leukocytes are abundant.
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intensity around the head of the right femur indicating
fluid collection (Figure 3A). Fat-saturated T2-weighted
images (T2WI) revealed another area of high intensity
on the right obturator externus or adducent muscles
(Figure 3B), suggesting right hip arthritis that 67gallium
scintigraphy confirmed as a hotspot (Figure 3C). Joint
drainage fluid collected on day 100 showed abundant
leukocytes enclosed by phagocytic gram-positive cocci
(Figure 3D) that were later identified as MRSA. Pulsed-A
C
Figure 3 Magnetic resonance imaging of right hip joint. T2-weighted i
of right femur, indicating fluid collection (A). Fat saturated T2WI shows hig
that appears as a hotspot on gallium scintigram (C). Synovial fluid contains
positive cocci (D).field gel electrophoresis (PFGE) showed that the MRSA
strains in the samples isolated from stool (day 19), blood
(day 30) and synovial fluid (day 100) were identical
(Figure 4), suggesting a hematological spread of MRSA
originating from the colonic membrane damaged by
MRSA enterocolitis. The PFGE profiles of two strains
isolated from sputum on days 10 and 44 and that of a
strain isolated from a catheter tip on day 20 were similar,
but all three strains differed by one band from strains
isolated from stool, blood and synovial fluid specimens.
These strains were considered to be derived from the
same clone with different subtypes according to Teno-
ver's criteria [1], and they had the same antibiogram
(VCM ≤ 1, teicoplanin ≤ 1, linezolide 2). These findings
suggested that persistent colonized MRSA could co-
evolve even in a host environment.
None of the findings were consistent with the criteria
for confirmed toxic shock syndrome (TSS; fever > 38.9°C,
hypotension ≤ 90 mmHg), diffuse erythroderma, desquam-
ation (unless death occurs before desquamation) and the
involvement of at least three organ systems) or probable
TSS (missing one characteristic for confirmed TSS) [2] or
pseudomembranous colitis. Thus, he was finally diagnosed
with MRSA enterocolitis that subsequently caused septic
arthritis in the right hip.
Indeed, multilocus sequence typing confirmed that the
allelic profiles of the MRSA strains obtained from blood,
sputum and synovial fluid on days 30, 45 and 100,B
D
mage (T2WI) of hip joint shows high-intensity area surrounding head
h-intensity area on right obturator externus or adducent muscles (B)
abundant leukocytes that are phagocytically engulfed by gram-
M       1        2       3        4        5        6        C  
Figure 4 Analysis of identified methicillin-resistant Staphylococcus
aureus strains on pulsed-field gel electrophoresis. M, marker; 1,
sputum (day 10); 2, stool (day 19); 3, intravenous hyperalimentation
catheter (day 20); 4, blood (day 30); 5, sputum (day 44); 6, hip joint
synovial fluid (day 100); C, control (Staphylococcus aureus, strain
NCTC 8325).
Table 1 Toxin gene profiles and multilocus sequence typing o
synovial fluid
Source Detection of toxic genes
tst eta etb sea seb sec sed see seg seh sei sej pvl
A. blood - - - - - - - - + - + - -
Sputum - - - - - - - - + - + - -
Joint fluid - - - - - - - - + - + - -
A: acetyltransferase, arc: carbamate kinase, aro: shikimate dehydrogenase, CC: clona
etb: exfoliatin toxin b, glp: glycerol kinase, gmk: guanylate kinase, MLST: multilocus
leukocidine, sea: staphylococcal enterotoxin a, seb: staphylococcal enterotoxin b, se
coccal enterotoxin g, seh: staphylococcal enterotoxin h, sei: staphylococcal enteroto
chromosmome mec, ST: sequence type, tpi: triosephosphate isomerase, yqi: acetyle
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quence type (ST) 764, clonal complex (CC) 5 [3] and
carried SCCmec type II. These strains carried entero-
toxins G and I, but no other SEs or TSST-1. Our patient
was discharged uneventfully on day 156 after completing
a two-month course of oral linezolide (1200 mg/day)
with intravenous clindamycin (CLDM; 1200 mg/day)
followed by teicoplanin (400 mg/day) with intravenous
CLDM (1200 mg/day) infusion.Discussion
MRSA enterocolitis has been identified among Japanese
patients since 1985, especially after undergoing gastric
resection [4] or being medicated with a third-generation
cephalosporin [5]. Although many studies of MRSA en-
terocolitis have proceeded in Japan, MRSA is not a fre-
quent cause of antibiotic-associated diarrhea and this
notion has remained a matter of debate, as anecdotally
reported elsewhere [6]. Therefore, to summarize and
characterize published reports of MRSA enterocolitis in
Japan, we intensively reviewed studies over the past dec-
ade (Table 2) [7-24]. We identified 36 (male, n = 28;
female, n = 8) patients (age range, 0 to 91 y; mean ± SD;
59.5 ± 21.3 y) who required a median of seven (range,
2–40) days of antibiotics to treat MRSA enterocolitis
that was mainly diagnosed from stool cultures. Two
were diagnosed at autopsy (patients 1 and 3) and one
each was diagnosed by colonoscopy (patient 2) and dur-
ing surgery (patient 4). Importantly, SEs or TSST-1 have
been assessed in only four (11.1%) patients (Nos. 1, 5, 6
and 8); two of them had enterotoxin C and all four had
TSST-1. Furthermore, our review of two reports [12,13]
found that patients No. 5 and 6 (Table 2) satisfied the
criteria for TSS with typical erythema and desquamation,
but the authors had diagnosed them with MRSA
enterocolitis. The other two patients (Nos.1 and 8) with
TSST-1 did not satisfy the criteria for TSS. None of the
other patients with MRSA enterocolitis had cutaneous








arcC aroE glpF gmk pta tpi yqil ST CC
A 2 II 1 136 1 4 12 1 10 764 5
A 2 II 1 136 1 4 12 1 10 764 5
A 2 II 1 136 1 4 12 1 10 764 5
l complex, ccr: cassette chromosome recombinase, eta: exfoliatin toxin a
sequence typing, pta: phosphate acetyltransferase, pvl: Panton-Valentine
c: staphylococcal enterotoxin c, sed: staphylococcal enterotoxin d, seg: staphylo-
xin I, sej: staphylococcal enterotoxin j, SCCmec: Staphylococcal casstte
coenzyme.
Table 2 Summary of methicillin-resistant Staphylococcus aureus enterocolitis reported in Japan over the past 10 years







1 66 M Appendectomy Autopsy All digestive
tract
NA NA/II/+ D 9
2 31 M Acute pancreatitis Stool culture with
Biopsy
Colon 12 NA D 10
3 47 F UTI Autopsy Small
Intestine
10 NA D 7
4 73 M Esophageal Ca, Gastric CA POS Ileum interposition none 19 NA A 11
5 59 M Gastric Ca Stool culture NA NA C/NA/+ A 12
6 23 M Infected pilonidal sinus POS NA NA 15 -/−/+ A 13
7 71 M Peritonitis with mediastinitis
POS
NA NA 18 NA A 14
8 72 M Panperitonitis POS Stool culture NA 3 A/II/+ A 15
9 26 F Tongue Ca POS Stool culture NA 7 NA D 16
10 75 F Gallbladder Ca NA NA NA NA D 8
11 64 M Pancreatitis Stool culture NA NA NA A 17
12 73 F Pancreatitis Stool culture NA NA NA A 17
13 44 M Pancreatitis Stool culture NA NA NA D 17
14 77 M Pneumonia Stool culture NA 42 NA A 18
15 78 M Ileus POS Stool culture NA 20 NA A 19
16 78 F Intestinal perforation POS Stool culture NA NA NA D 20
17 39 M Acute mandibular periostitis Stool culture NA 8 NA A 21
18 60 M Lung Ca small intestine
metastasis POS
NA NA 7 NA A 22
19 84 M Pneumatosis cystoides
intestinalis
Stool culture NA NA NA A 23
20 71 M AMI, CABG Stool culture NA 3 NA A 24
21 73 M Sigmoid colon Ca POS Stool culture NA 2 NA A
22 63 M Rectum Ca POS Stool culture NA 2 NA A
23 78 M UTI Stool culture NA 4 NA A
24 91 F Pneumonia, cholecystitis Stool culture NA NA NA A
25 59 M Esophageal Ca POS Fecal properties NA 4 NA A
26 70 F Perforation of sigmoid colon
Ca POS
Stool culture NA 4 NA A
27 64 M Perforation of amebic colitis
POS
NA NA 4 NA A
28 0 M BA Stool culture NA 7 NA A
29 18 M Lymphoblastic lymphoma T-
cell type
Stool culture NA NA NA A
30 64 M Renal abscess NA NA NA NA A
31 88 F Pneumonia NA NA 9 NA A
32 64 M Pancreatic Ca POS Stool culture NA NA NA A
33 62 M Ileus Fluid drainage from
ileus tube
NA 5 NA A
34 66 M Esophageal Ca POS NA NA NA NA A
35 26 M ALL Stool culture NA 14 NA D
36 47 M Ileus NA NA 9 NA D
A, alive; ALL, acute lymphocytic leukemia; AMI, acute myocardial infarction; BA, bronchial asthma; Ca, carcinoma; CABG, coronary artery bypass grafting; D, dead;
Duration*, duration of preceding antibiotics therapy to diagnosis of MRSA enterocolitis; NA, not available; POS, postoperative status; Prog, prognosis; Pt. No,
patient number; TSST-1, toxic shock syndrome toxin-1; UTI, urinary tract infection; All patients were described in Japanese and only patients 1 to 20 have been
published in English and are cited as references.
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organ failure and pyrexia due to MRSA bacteremia, but
it should be differentiated from TSS regardless of the
presence of TSST-1.
Although enterotoxins (A, A and B, D [6] or C [25,26],
and the bicomponent leukotoxin LukE-LukD [27]) have
been detected in strains associated with MRSA entero-
colitis, the relevance to this disease of enterotoxins G
and/or I that were recognized in our patient remains un-
known. Humans are natural reservoirs of S. aureus, with
intermittent colonization occurring in 30% - 50% of
healthy adults [28], 10% of whom harbor this micro-
organism in the gastrointestinal tract [29]. The ratio of
nasal MRSA carriage among healthy individuals in Japan
is similarly high, at 38.0% [30]. In contrast, another re-
port stated that most hospitalized geriatric patients car-
rying MRSA in the gastrointestinal space were treated
with antibiotics [31]. These facts imply that most of the
reported “MRSA enterocolitis” in Japan might have been
caused by preceding antibiotic use and/or presented
with one of the clinical features of superantigen-derived
toxic shock syndrome due to TSST-1 or undetermined
effects of SEs other than those described above. In
addition, colonization of MRSA in the digestive tract
after antibiotic use might have been misdiagnosed in
some patients as a pathogen for diarrhea of undeter-
mined causes.
Boyce et al. [6] reported that among five patients with
MRSA enterocolitis in whom fecal leukocytes were ex-
amined, two were positive, like our patient. They also
stated that the duration of preceding antimicrobial ther-
apy ranged from 2 to 21 days, which is similar to that of
other Japanese reports indicating a range of 2 to 42 days
(Table 2). Boyce et al. [6] also reported that the max-
imum recorded stool volume per 24 h period ranged
from 475 to 8,250 mL in 11 patients with MRSA entero-
colitis and that the total volume of stool recorded for
the entire diarrheal illness ranged from 745 mL to
38.85 L, which was identical to that of our patient and
other reports (maximum recorded stool volume per 24 h
ranged from 500 mL to 4.0 L from patient Nos. 9, 15, 33
and the present patient). Froberg et al. [32] reported that
MRSA enterocolitis features loosely adherent pseudo-
membranes in the small intestine, whereas C. difficile
pseudomembranous colitis locates in the colon where
pseudomembranes are tightly adherent. Indeed, the sites
of inflammation in patients 1, 2, 3 and 4 in our review
comprised the gastric wall (patient 1 at autopsy), small
intestine (patient 3 at autopsy; patient 4 by biopsy), or
colon (patient 2, by biopsy), indicating that the preferred
site of MRSA enterocolitis is the small intestine. Cul-
tured samples from all four patients were positive for
MRSA, but only patients 3 and 4 had white pseudo-
membranes at the small intestine that were MRSA-positive. Although pathological information is scant,
MRSA enterocolitis can involve not only the small intes-
tine, but also the colon (Table 2).
Colonic fiberscopy indicated that our patient had no
apparent pseudomembranes up to the sigmoid portion.
Nonetheless, MRSA enterocolitis was the most likely
source of the massive diarrhea because C. difficile toxin
A/B was negative, MRSA was the dominant organism
isolated from abundant fecal leukocytes, the watery diar-
rhea was refractory to metronidazole but susceptible to
oral VCM and suppurative MRSA arthritis of the right
hip joint occurred after the watery diarrhea or transient
MRSA bacteremia were identified. Watanabe et al. [33]
found identical (69.2%) or similar (23.1%) PFGE profiles
in 12 of 13 samples obtained from the respiratory tract
(nasal cavity and/or pharynx and/or sputum) and stool
samples from patients infected with MRSA. They specu-
lated that one cause of enterocolitis could be MRSA that
originated from colonization of the respiratory tract and
was absorbed into the digestive tract. A single genetic
event in MRSA strains colonizing the respiratory tract
might generate a new MRSA strain that could cause en-
terocolitis, septicemia and septic arthritis. As the toxin
gene profiles among strains from blood, synovial fluid
and sputum were identical on MLST (SCCmec type II,
ST764, CC5), whether or not a single minor genetic
change could alter virulence remains uncertain. Further
studies are required to clarify the reason for the change
in virulence.
The MRSA strain derived from stool cultures did not
thrive. Thus, we could not perform MLST after obtain-
ing convincing PFGE results. Nevertheless, we postulate
that our patient had MRSA enterocolitis that was se-
quentially complicated with septic arthritis. The relation-
ship between MRSA enterocolitis and SEs or TSST-1
together with pathological assessments that could im-
prove understanding of the pathological process involved
in MRSA enterocolitis require further exploration.Conclusion
Any MRSA isolated from patients with diarrhea that is
refractory to treatment should be assessed from a multi-
disciplinary viewpoint considering colonization or patho-
gens. Our review of published reports suggests that the
clinical features MRSA enterocolitis mimic those of TSS,
which might reflect undetermined effects of SEs or
TSST-1 associated with MRSA infection.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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